Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Clinical trial NCT01779518 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01779518
- Sponsor
- Gilead Sciences
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.